Results

Total Results: 45 records

Showing results for "aspirin".

21. Jan-2017-Cholesterol-Wg-Notes (doc file)
    cds.ahrq.gov/sites/default/files/workgroups/216/jan-2017-cholesterol-wg-notes.docx
    January 01, 2017 - treated) and the Longitudinal Risk Assessment Tool (targeted at patients already following statin and/or aspirin … artifacts in alignment with other quality measures: · Statin use for primary prevention (PQRS#438) · Aspirin

22. CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Updated 10-Year ASCVD Risk (April 2021) (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/81/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%2010-Year%20ASCVD%20Risk.pdf
    January 01, 2010 - based on both the baseline risk and the change in risk score from a preventive intervention (i.e., aspirin … associated with institution of one or more preventive interventions, including smoking cessation, aspirin … is based on both the baseline risk and the expected benefit from a preventive intervention (i.e., aspirin … logic: Presence of a 10-Year ASCVD risk score in the patient record, followed by the start of: aspirin … therapy (yes/no – determined by an aspirin medication) Calculate prospective risk scores Display

23. CDS Connect: Final Report 2024 (pdf file)
    cds.ahrq.gov/sites/default/files/CDS_Connect_2024_Final_Report.pdf
    January 01, 2024 - Treatment of CVD: An eCQM-derived CDS • Prediabetes and Type 2 Diabetes (screening and counseling) • Aspirin … prediabetes-and-type-2-diabetes-part-two-counseling https://cds.ahrq.gov/cdsconnect/artifact/uspstf-aspirin-therapy-primary-prevention-cardiovascular-disease

24. CDS Connect September 2021 Work Group Meeting (pdf file)
    cds.ahrq.gov/sites/default/files/workgroups/33746/CDS_Connect_WG_Presentation_September_2021.pdf
    January 01, 2021 - new evidence, per USPSTF; Value sets updated; CQL updated for R4; metadata updated with posted IG • Aspirin … statin-use-primary-prevention-cvd-adults-patient-facing-cds-intervention https://cds.ahrq.gov/cdsconnect/artifact/aspirin-therapy-primary-prevention-cvd-and-colorectal-cancer

25. CDS Connect Implementation Guide Draft (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/76/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making_Final_0.docx
    October 01, 2017 - be associated with institution of one or more preventive interventions, including smoking cessation, aspirin … current parameters, but also the modification in risk expected if statins, hypertension treatment, aspirin … Bravo and her clinician can then manipulate the boxes in the calculator for statins, aspirin, blood pressure … score if they are already in place (i.e., if the patient is already a nonsmoker; already on statins, aspirin … It is based on both the baseline risk and the expected benefit from a preventive intervention (i.e., aspirin

26. CDS Connect Implementation Guide Draft (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/81/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%20Risk_Final_0.docx
    October 01, 2017 - It is based on both the baseline risk and the expected benefit from a preventive intervention (i.e., aspirin … be associated with institution of one or more preventive interventions, including smoking cessation, aspirin … baseline calculation documented and who has begun new interventions in the intervening period, including aspirin … It is based on both the baseline risk and the expected benefit from a preventive intervention (i.e., aspirin … therapies" One or more of the following: smoking cessation, hypertension treatment, statin therapy or aspirin

27. Pain Management Summary Clincial Decision Support Toolkit For Repository (xls file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository.xlsx
    January 01, 2003 - Oral Capsule F16.980 Hallucinogen use, unspecified with hallucinogen-induced anxiety disorder 103954 Aspirin … Tablet M54.17 Radiculopathy, lumbosacral region 1053658 Fentanyl 0.4 MG Sublingual Tablet 1312713 Aspirin … 1486992 Glucosamine Sulfate 500 MG Chewable Tablet F41.8 Other specified anxiety disorders 104475 Aspirin … 325 MG / butalbital 50 MG Oral Tablet F10.129 Alcohol abuse with intoxication, unspecified 106809 Aspirin … 0.4 MG/ML Injectable Solution 891874 Morphine Sulfate 100 MG Extended Release Oral Tablet 238135 Aspirin

28. Pain Management Summary Clincial Decision Support Toolkit For Repository 0 (xls file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository_0.xlsx
    January 01, 2003 - Oral Capsule F16.980 Hallucinogen use, unspecified with hallucinogen-induced anxiety disorder 103954 Aspirin … Tablet M54.17 Radiculopathy, lumbosacral region 1053658 Fentanyl 0.4 MG Sublingual Tablet 1312713 Aspirin … 1486992 Glucosamine Sulfate 500 MG Chewable Tablet F41.8 Other specified anxiety disorders 104475 Aspirin … 325 MG / butalbital 50 MG Oral Tablet F10.129 Alcohol abuse with intoxication, unspecified 106809 Aspirin … 0.4 MG/ML Injectable Solution 891874 Morphine Sulfate 100 MG Extended Release Oral Tablet 238135 Aspirin

29. Warfarin-Antidepressants Mdia Implementation Guide (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1146/Warfarin-Antidepressants%20MDIA%20Implementation%20Guide.docx
    August 29, 2020 - considered for major bleeding: · History of Gastrointestinal Bleeds · Older than 64 years of age · NSAIDs · Aspirin … gastrointestinal bleeds NSAID value set VSAC value set containing RxCUI’s for NSAID drugs Aspirin … value set VSAC value set containing RxCUI’s for aspirin drugs Systemic Corticosteroids value set

30. March 2020 CDS Connect Work Group Call (pdf file)
    cds.ahrq.gov/sites/default/files/workgroups/1131/CDS%20Connect%20Work%20Group%20March%202020%20Meeting%20Slides.pdf
    March 01, 2020 - cholesterol, systolic blood pressure, use of statin therapy, antihypertensive medication, use of aspirin

31. CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation%20Guide_CMS%20Million%20Hearts_ASCVD%20Risk%20Assessment_Level3_Final.pdf
    February 01, 2018 - associated with institution of one or more preventive interventions, including smoking cessation, aspirin … evaluate and track a “baseline” low-density lipoprotein (LDL) value, or treatment with statin therapy or aspirin … Implementation guidance “LDL”, “Statin Therapy” and “Aspirin Therapy” The concepts of LDL, statin … therapy, and aspirin therapy are not required or evaluated against to determine baseline ASCVD risk … evaluate and track a “baseline” low-density lipoprotein (LDL) value, or treatment with statin therapy or aspirin

32. CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation%20Guide_CMS%20Million%20Hearts_ASCVD%20Risk%20Assessment_Level3_Sept_08.pdf
    February 01, 2018 - associated with institution of one or more preventive interventions, including smoking cessation, aspirin … evaluate and track a “baseline” low-density lipoprotein (LDL) value, or treatment with statin therapy or aspirin … Implementation guidance “LDL”, “Statin Therapy” and “Aspirin Therapy” The concepts of LDL, statin … therapy, and aspirin therapy are not required or evaluated against to determine baseline ASCVD risk … evaluate and track a “baseline” low-density lipoprotein (LDL) value, or treatment with statin therapy or aspirin

33. CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation_Guide_CMS_Million_Hearts_ASCVD_Risk_Assessment.pdf
    September 01, 2021 - evaluate and track a “baseline” low-density lipoprotein (LDL) value, or treatment with statin therapy or aspirin … Implementation guidance “LDL,” “Statin Therapy,” and “Aspirin Therapy” The concepts of LDL, … statin therapy, and aspirin therapy are not required or evaluated against to determine baseline ASCVD … evaluate and track a “baseline” low-density lipoprotein (LDL) value, or treatment with statin therapy or aspirin

34. CDS Connect Maintenance and Update Final Report Year 4 2020 (pdf file)
    cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2020.pdf
    January 01, 2020 - No Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part Two, Counseling No Yes Yes No Aspirin … abnormal-blood-glucose-and-type-2-diabetes-mellitus-part-two-counseling https://cds.ahrq.gov/cdsconnect/artifact/aspirin-therapy-primary-prevention-cvd-and-colorectal-cancer … https://cds.ahrq.gov/cdsconnect/artifact/aspirin-therapy-primary-prevention-cvd-and-colorectal-cancer … https://cds.ahrq.gov/cdsconnect/artifact/aspirin-therapy-primary-prevention-cvd-and-colorectal-cancer

35. CDS Connect Maintenance and Update Final Report (Year 5 of CDS Connect) (pdf file)
    cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2021.pdf
    January 01, 2021 - Yes Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part Two, Counseling No Yes Yes Yes Aspirin … abnormal-blood-glucose-and-type-2-diabetes-mellitus-part-two-counseling https://cds.ahrq.gov/cdsconnect/artifact/aspirin-therapy-primary-prevention-cvd-and-colorectal-cancer … https://cds.ahrq.gov/cdsconnect/artifact/aspirin-therapy-primary-prevention-cvd-and-colorectal-cancer … https://cds.ahrq.gov/cdsconnect/artifact/aspirin-therapy-primary-prevention-cvd-and-colorectal-cancer

36. CDS Connect - Year 1 Final Report (pdf file)
    cds.ahrq.gov/sites/default/files/reports/AHRQ_Final_Report_2017.pdf
    January 01, 2017 - Further, the USPSTF had recommendations on aspirin use. … cholesterol management: • ACC/AHA statin therapy recommendation statements • USPSTF statin therapy and aspirin … IP Approval USPSTF Statin Use for Primary Prevention of CVD in Adults Structured Yes USPSTF Aspirin

37. CDS Connect - Maintenance and Update Final Report (Year 6) (pdf file)
    cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2022.pdf
    January 01, 2022 - Yes Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part Two, Counseling Yes Yes Yes Yes Aspirin … Notably, the update for the Aspirin Therapy for Primary Prevention of CVD and Colorectal Cancer was

38. Final Report, Year 3: CDS Connect (pdf file)
    cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2019.pdf
    January 01, 2019 - Screening AHRQ Structured 9/11/2019 Anthrax Post-Exposure Prophylaxis CDC Structured 10/25/2018 Aspirin … cds.ahrq.gov/cdsconnect/artifact/anthrax-post-exposure-prophylaxis https://cds.ahrq.gov/cdsconnect/artifact/aspirin-therapy-primary-prevention-cvd-and-colorectal-cancer … https://cds.ahrq.gov/cdsconnect/artifact/aspirin-therapy-primary-prevention-cvd-and-colorectal-cancer

39. Factors to Consider in Managing Chronic Pain: A Pain Management Summary (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/ImplementationGuidePainManagementSummary508_with%202020%20updates%202.pdf
    May 01, 2020 - Medications with analgesic effects which may provide therapeutic benefit in treating chronic pain (including aspirin

40. Implementation Guide: Factors to Consider in Managing Chronic Pain: A Pain Management Summary (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/ImplementationGuidePainManagementSummary50810012018.pdf
    December 01, 2018 - Medications with analgesic effects which may provide therapeutic benefit in treating chronic pain (including aspirin